The Ottawa Hospital will produce three candidate novel coronavirus vaccines ahead of their clinical trials, providing what could be a critical function for Canada’s long-term fight against COVID-19 and other pandemics down the line.The local hospital’s research institute announced this week that it will manufacture Edmonton-based Entos Pharmaceuticals’ Covigenix vaccine candidate ahead of Stage 1 clinical trials.
The Ottawa Hospital said it also has deals in place to manufacture two other undisclosed vaccines, but details of those candidates will come at a later date.